851577-39-4

Basic information

• Product Name: 3-Pyridinecarboxylic acid, 5-cyano-1,4-dihydro-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)-, methyl ester
• CAS NO: 851577-39-4
• Molecular Formula: C20H24N2O2
• Molecular Weight: 324.423
• Mol File: 851577-39-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-Pyridinecarboxylic acid, 5-cyano-1,4-dihydro-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxylic acid, 5-cyano-1,4-dihydro-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)-, methyl ester(851577-39-4)
• EPA Substance Registry System: 3-Pyridinecarboxylic acid, 5-cyano-1,4-dihydro-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)-, methyl ester(851577-39-4)

Safety Data

• Hazardous Substances Data: 851577-39-4(Hazardous Substances Data)

Upstream product

• 907611-08-9 5-methyl-2-[(4-methylphenyl)methylidene]-3-oxohexanenitrile 
• 14205-39-1 methyl 3-aminocrotonate 
• 64373-43-9 5-methyl-3-oxo-hexanenitrile 
• 556-24-1 methyl 3-methylbutanoate 
• 14205-39-1 methyl (E)-3-aminocrotonate 
• 104-87-0 4-methyl-benzaldehyde 
• 21731-17-9 methyl 3-aminocrotonate 

Downstream Products

• 1262861-31-3 tert-butyl {[5-{2-[(3-carbamoylphenyl)amino]-2-oxoethyl}-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl]methyl}carbamate 
• 1262861-32-4 tert-butyl {[5-{2-[(3-acetylphenyl)amino]-2-oxoethyl}-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl]methyl}carbamate 
• 1262861-33-5 tert-butyl {[6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)-5-(2-{[3-(methylsulfanyl)phenyl]amino}-2-oxoethyl)-pyridin-3-yl]methyl}carbamate 
• 907611-40-9 tert-butyl {[6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)-5-(2-{[3-(methylsulfonyl)phenyl]amino}-2-oxoethyl)-pyridin-3-yl]methyl}carbamate 
• 851586-42-0 methyl 4-({[5-{[(tert-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]-acetyl}amino)thiophene-3-carboxylate 
• 1262861-35-7 methyl N-{[5-{[(tert-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]-acetyl}glycinate 
• 851586-54-4 methyl 1-{[5-{[(tert-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]-acetyl}-L-prolinate 
• 907611-36-3 tert-butyl {[5-{2-[(2S)-2-carbamoylpyrrolidin-1-yl]-2-oxoethyl}-6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)-pyridin-3-yl]methyl}carbamate 
• 1262861-36-8 methyl 1-{[5-{[(tert-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]-acetyl}-D-prolinate 
• 1262861-37-9 methyl 1-{[5-{[(tert-butoxycarbonyl)amino]methyl}-2-methyl-4-(4-methylphenyl)-6-(2-methylpropyl)pyridin-3-yl]-acetyl}pyrrolidine-3-carboxylate 
• 1262861-38-0 tert-butyl {[6-methyl-4-(4-methylphenyl)-2-(2-methylpropyl)-5-{2-[3-(methylsulfonyl)pyrrolidin-1-yl]-2-oxoethyl}-pyridin-3-yl]methyl}carbamate 
• 1262861-39-1 tert-butyl ({6-methyl-5-[2-(methylamino)-2-oxoethyl]-4-(4-methylphenyl)-2-(2-methylpropyl)pyridin-3-yl}methyl)-carbamate 

Relevant articles and documents

Discovery of a 3-pyridylacetic acid derivative (TAK-100as a potent, selective and orally active dipeptidyl peptidase IV (DPP-4) inhibitor

Inhibition of dipeptidyl peptidase IV (DPP-4is an exciting new approach for the treatment of diabetes. To date there has been no DPP-4 chemotype possessing a carboxy group that has progressed into clinical trials. Originating from the discovery of the str

REMEDY FOR DIABETES

The present invention provides an agent for increasing the pancreatic insulin content useful for the treatment of diabetes and the like. In one embodiment, the present invention provides an agent for increasing the pancreatic insulin content, which contai

PYRIDINE COMPOUNDS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV

A compound represented by the formula wherein R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted hydroxy group; R3 is an optionally substituted aromatic group; R4 is an optionally substituted amino group; L is a divalent chain hydrocarbon group; Q is a bond or a divalent chain hydrocarbon group; and X is a hydrogen atom, a cyano group, a nitro group, an acyl group, a substituted hydroxy group, an optionally substituted thiol group, an optionally substituted amino group or an optionally substituted cyclic group; provided that when X is an ethoxycarbonyl group, then Q is a divalent chain hydrocarbon group. The compound has a peptidase inhibitory action, is useful as an agent for the prophylaxis or treatment of diabetes and the like, and is superior in efficacy, duration of action, specificity, lower toxicity and the like.